![The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma - Zhu - 2019 - Cancer Medicine - Wiley Online Library The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma - Zhu - 2019 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0d3e182b-9a2f-4547-b1ad-7c5d470fd115/cam42217-fig-0004-m.jpg)
The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma - Zhu - 2019 - Cancer Medicine - Wiley Online Library
![Tumour markers fluctuations in patients with medullary thyroid carcinoma receiving long-term RET inhibitor therapy: ordinary lapping or alarming waves foreshadowing disease progression? | Semantic Scholar Tumour markers fluctuations in patients with medullary thyroid carcinoma receiving long-term RET inhibitor therapy: ordinary lapping or alarming waves foreshadowing disease progression? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/72bda67791e6d3aa9c452842ebd1a55b1bbbcfcd/2-Table1-1.png)
Tumour markers fluctuations in patients with medullary thyroid carcinoma receiving long-term RET inhibitor therapy: ordinary lapping or alarming waves foreshadowing disease progression? | Semantic Scholar
![Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//15750922/0000006200000004/v2_201503200439/S1575092215000327/v2_201503200439/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNf23BlP/DWEpPOpuWlfofnyU0Zzc7C+spQedaWXFRWdfa8E9RzH5OP6vqtd1YS/HjxOdTYJx4RbzWm1a7GceCWP3qYF4inzpywlsiBYzFsxK/QwT1Nm5JzzqbYwZvjC2q1Y6/y4423nzIlPJCY9uaPs2ZTbhP6Sb7en8QVZki5EDYklbWH3IwZb0lEkN4XZZudXAV2NXGAe+8oh+DoRQXjNMtX/hXtUlA3F/wvqP/Z25w+eWjEPrmJK3L+9gL4+cu0=)
Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for
![IJMS | Free Full-Text | The Impact of Transcription Factor Prospero Homeobox 1 on the Regulation of Thyroid Cancer Malignancy IJMS | Free Full-Text | The Impact of Transcription Factor Prospero Homeobox 1 on the Regulation of Thyroid Cancer Malignancy](https://www.mdpi.com/ijms/ijms-21-03220/article_deploy/html/images/ijms-21-03220-g001.png)
IJMS | Free Full-Text | The Impact of Transcription Factor Prospero Homeobox 1 on the Regulation of Thyroid Cancer Malignancy
![Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer - ScienceDirect Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0163725820302394-gr1.jpg)
Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer - ScienceDirect
![Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives in: Endocrine-Related Cancer Volume 26 Issue 9 (2019) Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives in: Endocrine-Related Cancer Volume 26 Issue 9 (2019)](https://erc.bioscientifica.com/view/journals/erc/26/9/images/ERC-18-0574fig3.jpeg)
Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives in: Endocrine-Related Cancer Volume 26 Issue 9 (2019)
![Triple-negative” non-secretory medullary thyroid cancer: uncommon pathological findings in a rare disease Triple-negative” non-secretory medullary thyroid cancer: uncommon pathological findings in a rare disease](https://www.archivesofmedicalscience.com/f/fulltexts/147431/AMS-18-3-147431-g002.jpg)
Triple-negative” non-secretory medullary thyroid cancer: uncommon pathological findings in a rare disease
![Treatment algorithm for clinically apparent medullary thyroid cancer.... | Download Scientific Diagram Treatment algorithm for clinically apparent medullary thyroid cancer.... | Download Scientific Diagram](https://www.researchgate.net/publication/5334812/figure/fig4/AS:670457334349825@1536860893101/Treatment-algorithm-for-clinically-apparent-medullary-thyroid-cancer-Abbreviations-CEA.png)
Treatment algorithm for clinically apparent medullary thyroid cancer.... | Download Scientific Diagram
![Frontiers | Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center Frontiers | Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center](https://www.frontiersin.org/files/Articles/747704/fendo-12-747704-HTML/image_m/fendo-12-747704-g001.jpg)
Frontiers | Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center
![Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome | Modern Pathology Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41379-020-0532-1/MediaObjects/41379_2020_532_Fig1_HTML.png)
Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome | Modern Pathology
![Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy - Annals of Oncology Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/5df25b03-5a91-41c0-9f17-ee77ea677bc7/gr1.jpg)
Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy - Annals of Oncology
![Frontiers | Medullary Thyroid Carcinoma With Elevated Serum CEA and Normal Serum Calcitonin After Surgery: A Case Report and Literature Review Frontiers | Medullary Thyroid Carcinoma With Elevated Serum CEA and Normal Serum Calcitonin After Surgery: A Case Report and Literature Review](https://www.frontiersin.org/files/Articles/526716/fonc-10-526716-HTML/image_m/fonc-10-526716-g001.jpg)
Frontiers | Medullary Thyroid Carcinoma With Elevated Serum CEA and Normal Serum Calcitonin After Surgery: A Case Report and Literature Review
![Targeted Therapy for Endocrine Cancer: The Medullary Thyroid Carcinoma Paradigm - Endocrine Practice Targeted Therapy for Endocrine Cancer: The Medullary Thyroid Carcinoma Paradigm - Endocrine Practice](https://www.endocrinepractice.org/cms/asset/e178380c-19f8-4e03-81eb-5f657bd491de/gr1.jpg)